Eileen M. Denovan‐Wright

Author

Also Known As

Denovan-Wright, Eileen M., E M Denovan-Wright, E M Denovan‐Wright, E. M. Denovan-Wright, E. M. Denovanwright, E. M. Denovan‐Wright, E.M Denovan-Wright, E.M. Denovan‐Wright, Eileen Denovan-Wright, Eileen Denovan‐Wright

117

Publications

Citations

H-Index

115

Concepts

All Affiliations

Dalhousie University University of Saskatchewan Institut de génétique et de biologie moléculaire et cellulaire University of Aberdeen Northeastern University

About

Eileen M. Denovan‐Wright is an author at Dalhousie University specializing in medicine, genetics, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	1.7K
2	Natural Sciences	13	13	411
3	Social Sciences	9	9	676
4	Health Sciences	3	3	108
5	Public Health	1	1	36

Eileen M. Denovan‐Wright

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Cannabidiol is a negative allosteric modulator of the cannabinoid CB <sub>1</sub> receptor Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, British Journal of Pharmacology	2015	960
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, British Journal of Pharmacology	2018	304
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice Edgardo Rodríguez-Lebrón, Eileen M. Denovan‐Wright, Kevin Nash, Molecular Therapy	2005	275
Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington′s disease transgenic mice prior to the onset of motor symptoms Andrea L.O. Hebb, H.A. Robertson, Eileen M. Denovan‐Wright Neuroscience Neurodegenerative DiseasesMolecular NeuroscienceProtein LevelsMotor DisorderNeurology	2004	174
Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington’s disease mice Eileen M. Denovan‐Wright, H.A. Robertson Neuroscience GeneticsCannabinoid PharmacologySynaptic SignalingSocial SciencesLateral Striatum	2000	168
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, Journal of Biological Chemistry PsychopharmacologyNeurotransmissionCellular NeurobiologyCannabinoid PharmacologySocial Sciences	2014	137
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, ACS Chemical Neuroscience	2017	106
Structure, expression and regulation of the cannabinoid receptor gene (<i>CB1</i>) in Huntington's disease transgenic mice Elizabeth A. McCaw, Haibei Hu, Geraldine T. Gomez, European Journal of Biochemistry	2004	103
Anti‐inflammatory effects of cannabinoid CB<sub>2</sub> receptor activation in endotoxin‐induced uveitis James Thomas Toguri, Christine Lehmann, Robert B. Laprairie, British Journal of Pharmacology	2013	93
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, Molecular Pharmacology	2015	93

Page 1